EVALUATION OF THE CHARACTERISTICS AND CLINICAL  RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19  PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL  EXPERIENCE

Benli Aysun; Resuloğlu Emir; Karadağlı İlke; Ceylan Ayşe; Yeler Mustafa; Danışan Gürkan; Büyüksütçü Cihan; Balcı Mehmet; Korkmaz Şinasi; Akdemir Bilal; Yıldıran Adil; Yaşar Cemal

doi:https://dx.doi.org/10.26650/IUITFD.2021.812574

Research Article

DOI :10.26650/IUITFD.2021.812574 IUP :10.26650/IUITFD.2021.812574 Full Text (PDF)

EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE

Aysun Benli, Emir Resuloğlu, İlke Karadağlı, Ayşe Nur Ceylan, Mustafa Taner Yeler, Gürkan Danışan, Cihan Büyüksütçü, Mehmet Balcı, Şinasi Korkmaz, Bilal Akdemir, Adil Akın Yıldıran, Cemal Yaşar

Objective: In this study, we aimed to determine the characteristics of COVID-19 pneumonia patients, and also predict factors affecting the severity of the disease. Methods: This is a retrospective, single-center study. Hospitalized COVID-19 pneumonia patients aged over 18 years between March 19th 2020, and May 19th 2020 were included in the study. The demographic, and clinical characteristics of patients, and factors associated with severe COVID-19 were analyzed. Multivariate logistic regression analysis was performed to evaluate the factors predicting the severity of COVID-19. Results: A total of 228 patients with COVID-19 pneumonia were recorded. The mean age of the patients was 51±19 years, and 136 (59.6%) were men. Of the patients, 47.4% had at least one comorbidity. Intensive care unit (ICU) admission, and mortality were detected in 29 (12.7%), and in 17 (7.5%) patients respectively. No mortality was detected in non-severe disease. Our results revealed that dyspnea (OR:7.449 95% CI 2.444-22.708, p<0.001), fatigue (OR:5.968 96% CI 2.155-16.526, p:0.001), elevation of LDH (OR: 4.288 95% CI 1.109-16.584, p:0.035) and elevation of D-dimer (OR:3.242 95% CI 1.106-9.501, p:0.032) levels at admission were major independent predicting factors for severe COVID-19 disease. Conclusion: Dyspnea, fatigue, elevation of LDH and D-dimer levels are closely related to severe disease in COVID-19. In addition to typical pneumonia signs, fatigue, LDH, and D-dimer can be used as valuable indicators at admission for distinguishing severe COVID-19 pneumonia patients in the early stage. Therefore, this may lead to improved outcomes in patients hospitalized with COVID-19.

Keywords: COVID-19, pneumonia, clinical characteristics, severity, predicting factors

DOI :10.26650/IUITFD.2021.812574 IUP :10.26650/IUITFD.2021.812574 Full Text (PDF)

TÜRKİYE’NİN MUŞ İLİNDEKİ COVID-19 PNÖMONİSİ NEDENİYLE HASTANEYE YATIRILAN HASTALARIN ÖZELLİKLERİ VE KLİNİK SONUÇLARININ DEĞERLENDİRİLMESİ: İKİNCİ BASAMAK HASTANE DENEYİMİ

Amaç: Bu çalışmada COVID-19 pnömonili hastalarının özelliklerini ve aynı zamanda hastalığın şiddetini etkileyen faktörleri belirlemeyi amaçladık. Gereç ve Yöntem: Çalışmamız tek merkezli, retrospektif bir çalışmadır. Çalışmaya 19 Mart - 19 Mayıs 2020 tarihlerinde hastanede yatan, 18 yaş ve üstü, COVID-19 pnömonili hasta dahil edildi. Hastaların demografik, klinik özellikleri ve şiddetli COVID-19 ile ilişkili faktörler analiz edildi. Şiddetli COVID-19’u öngören faktörleri değerlendirmek için çok değişkenli lojistik regresyon analizi yapıldı. Bulgular: COVID-19 pnömonisi olan toplam 228 hasta kaydedildi. Hastaların ortalama yaşı 51±19 yıldı, 136'sı (%59,6) erkekti. Hastaların %47,4'ünde en az bir komorbidite vardı. Yoğun bakım ünitesine (YBÜ) yatış ve ölüm sırasıyla 29 (%12,7) ve 17 (%7,5) hastada tespit edildi. Ağır olmayan hastalıkta ölüm tespit edilmedi. Başvuru anındaki dispne (OR:7,449 %95 CI 2,444-22,708, p<0,001), halsizlik (OR:5,968 %95 CI 2,155- 16,526, p:0,001), LDH yüksekliği (OR:4,288 %95 CI 1,109- 16,584, p:0,035) ve D-dimer yüksekliği (OR:3,242 %95 CI 1,106-9,501, p:0,032) şiddetli COVID-19 hastalığı için başlıca bağımsız öngörücü faktörlerdi. Sonuç: Dispne, halsizlik, LDH ve D-dimer seviyelerinin yükselmesi şiddetli COVID-19 ile yakından ilişkilidir. Tipik pnömoni belirtilerine ek olarak, ağır COVID-19 pnömonili hastaları erken evrede ayırt etmek için başvuru sırasındaki halsizlik, LDH ve D-dimer değerli göstergeler olarak kullanılabilir Başvuruda bu göstergeleri değerlendirmek COVID-19 ile hastaneye yatırılan hastalarda daha iyi sonuçlara yol açabilir.

Keywords: COVID-19, pnömoni, klinik özellikler, hastalık şiddeti, belirleyici faktörler

References

1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. [CrossRef] google scholar
2. World Health Organization (2020). WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 (cited 2020 September 3). [CrossRef] google scholar
3. Fahrettin Koca. Turkey remains firm, calm as first coronavirus case confirmed. Daily Sabah (cited 2020 September 3). [CrossRef] google scholar
4. World Health Organization (2020). WHO Coronavirus Disease (COVID-19) Dashboard (cited 2020 October 12). [CrossRef] google scholar
5. T.C. Sağlık Bakanlığı (2020). Türkiye COVID-19 Hasta Tablosu (cited 2020 October 12). [CrossRef] google scholar
6. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-42. [CrossRef] google scholar
7. Richardson S, Hirsch JS, Narasimhan M. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052-9. google scholar
8. T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü, COVID-19 (SARS-CoV-2 ENFEKSİYONU) GENEL BİLGİLER, EPİDEMİOLOJİ VE TANI, 29 June 2020 (cited 2020 July 3). Available from: URL: https://covid19.saglik. gov.tr/Eklenti/39060/0/covid19rehberigenelbilgiler epidemiyolojivetanipdf.pdf google scholar
9. World Health Organization (2020). Clinical management of COVID-19: Interim guidance (cited 2020 July 3). [CrossRef] google scholar
10. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA - Secondary Publication. J Thorac Imaging 2020;35(4):219-27. [CrossRef] google scholar
11. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 2020 Apr 9. [CrossRef] google scholar
12. Güner R, Hasanoğlu İ, Kayaaslan B, Aypak A, Kaya Kalem A, Eser F, et al. COVID-19 experience of the major pandemic response center in the capital: Results of the pandemic’s first month in Turkey. Turk J Med Sci 2020;50(8):1801-9. [CrossRef] google scholar
13. Başaran NÇ, Uyaroğlu OA, Dizman GT, Özişik L, Şahin TK, Taş Z, et al. Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU. Turk J Med Sci 2020 Jul 28. [CrossRef] google scholar
14. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020 Feb 28. [CrossRef] google scholar
15. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect 2020;26(6):767-72. [CrossRef] google scholar
16. Zhou F,Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. [CrossRef] google scholar
17. Pollitt KJG, Peccia J, Ko AI, Kaminski N, Cruz CSD, Nebert DW, et al. COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Human Genomics 2020 May 12 [CrossRef] google scholar
18. Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020 May 14 [CrossRef] google scholar
19. Xu PP, Tian RH, Luo S, Zu ZY, Fan B, Wang XM, et al. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study. Theranostics 2020;10(14): 6372-83. [CrossRef] google scholar
20. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395:1763-70. [CrossRef] google scholar
21. Karakoç ZÇ, Pınarbaşı-Şimşek B, Asil R, Dodurgalı R, Calışkaner F, Özsarı A, et al. First wave in COVID-19 pandemic: A single center experience. Klimik Dergisi 2020;33(3):223-9. [CrossRef] google scholar
22. Sümer Ş, Ural O, Aktuğ-Demir N, Çifci Ş, Türkseven B, Kılınçer A, et al. Clinical and laboratory characteristics of COVID-19 cases followed in Selçuk University Faculty of Medicine. Klimik Dergisi 2020;33(2):122-7. [CrossRef] google scholar
23. Gold JAW, Wong KK, Szablewski CM, Patel PR, Rossow J, Silva J, et al. Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020. MMWR Morb Mortal Wkly Rep 2020 May 8 [CrossRef] google scholar
24. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323(16):1574-81. [CrossRef] google scholar
25. Özger HS, Yıldız PA, Gaygısız Ü, Dikmen AU, Gülmez ZD, Yıldız M, et al. The factors predicting pneumonia in COVID-19 patients: preliminary results of a university hospital in Turkey. Turk J Med Sci 2020;50(8):1810-6. [CrossRef] google scholar
26. Tomlins J, Hamilton F, Gunning S, Sheehy C, Moran E et al. Clinical features of 95 sequential hospitalised patients] with novel coronavirus 2019 disease (COVID-19), the first UK cohort. J Infect 2020 Aug 8 [CrossRef] google scholar
27. Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B, et al. Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. J Infect 2020 Sep [CrossRef] google scholar
28. Characteristics of SARS-CoV-2 patients dying in Italy Report based on available data on October 4th, 2020 (cited 2020 October 6). [CrossRef] google scholar
29. Henry BM, Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58(7):1021-8. [CrossRef] google scholar
30. Han Y, Zhang H, Mu S, Wei W, Jin C, Tong C, et al. Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study. Aging 2020;12(12):11245-58. [CrossRef] google scholar
31. Henry BM, Aggarwal G, Wong J, Benoit S, Vikse J, Plebani M, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med 2020;38(9):1722-6. [CrossRef] google scholar
32. Wu M, Yao L, Wang Y, Zhu X, Wang X, Tang P, et al. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia. Respir Res 2020 Jul 6 [CrossRef] google scholar
33. Li J, Chen Z, Nie Y, Ma Y, Guo Q, Dai X, et al. Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province. J Med Internet Res 2020 Jun 30 [CrossRef] google scholar
34. Jain V, Yuan J. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health 2020 May 25 [CrossRef] google scholar
35. Hu C, Su F, Dai J, Lu S, Wu L, Chen D, et al. Prediction Model of Severe Coronavirus Disease 2019 (COVID-19) Cases Shows the Leading Risk Factor of Hypocalcemia. Research Square 2020 Jul 14 [CrossRef] google scholar
36. Rod JE, Trespalacios OO, Ramirez JC. A brief-review of the risk factors for covid-19 severity. Rev Saude Publica. 2020;54:60. [CrossRef] google scholar
37. Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care 2020 Jul 10 [CrossRef] google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format

EXPORT

APA

Benli, A., Resuloğlu, E., Karadağlı, İ., Ceylan, A.N., Yeler, M.T., Danışan, G., Büyüksütçü, C., Balcı, M., Korkmaz, Ş., Akdemir, B., Yıldıran, A.A., & Yaşar, C. (2021). EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE. Journal of Istanbul Faculty of Medicine, 84(2), 149-157. https://doi.org/10.26650/IUITFD.2021.812574

AMA

Benli A, Resuloğlu E, Karadağlı İ, Ceylan A N, Yeler M T, Danışan G, Büyüksütçü C, Balcı M, Korkmaz Ş, Akdemir B, Yıldıran A A, Yaşar C. EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE. Journal of Istanbul Faculty of Medicine. 2021;84(2):149-157. https://doi.org/10.26650/IUITFD.2021.812574

ABNT

Benli, A.; Resuloğlu, E.; Karadağlı, İ.; Ceylan, A.N.; Yeler, M.T.; Danışan, G.; Büyüksütçü, C.; Balcı, M.; Korkmaz, Ş.; Akdemir, B.; Yıldıran, A.A.; Yaşar, C. EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 84, n. 2, p. 149-157, 2021.

Chicago: Author-Date Style

Benli, Aysun, and Emir Resuloğlu and İlke Karadağlı and Ayşe Nur Ceylan and Mustafa Taner Yeler and Gürkan Danışan and Cihan Büyüksütçü and Mehmet Balcı and Şinasi Korkmaz and Bilal Akdemir and Adil Akın Yıldıran and Cemal Yaşar. 2021. “EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE.” Journal of Istanbul Faculty of Medicine 84, no. 2: 149-157. https://doi.org/10.26650/IUITFD.2021.812574

Chicago: Humanities Style

Benli, Aysun, and Emir Resuloğlu and İlke Karadağlı and Ayşe Nur Ceylan and Mustafa Taner Yeler and Gürkan Danışan and Cihan Büyüksütçü and Mehmet Balcı and Şinasi Korkmaz and Bilal Akdemir and Adil Akın Yıldıran and Cemal Yaşar. “EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE.” Journal of Istanbul Faculty of Medicine 84, no. 2 (May. 2024): 149-157. https://doi.org/10.26650/IUITFD.2021.812574

Harvard: Australian Style

Benli, A & Resuloğlu, E & Karadağlı, İ & Ceylan, AN & Yeler, MT & Danışan, G & Büyüksütçü, C & Balcı, M & Korkmaz, Ş & Akdemir, B & Yıldıran, AA & Yaşar, C 2021, 'EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE', Journal of Istanbul Faculty of Medicine, vol. 84, no. 2, pp. 149-157, viewed 17 May. 2024, https://doi.org/10.26650/IUITFD.2021.812574

Harvard: Author-Date Style

Benli, A. and Resuloğlu, E. and Karadağlı, İ. and Ceylan, A.N. and Yeler, M.T. and Danışan, G. and Büyüksütçü, C. and Balcı, M. and Korkmaz, Ş. and Akdemir, B. and Yıldıran, A.A. and Yaşar, C. (2021) ‘EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE’, Journal of Istanbul Faculty of Medicine, 84(2), pp. 149-157. https://doi.org/10.26650/IUITFD.2021.812574 (17 May. 2024).

MLA

Benli, Aysun, and Emir Resuloğlu and İlke Karadağlı and Ayşe Nur Ceylan and Mustafa Taner Yeler and Gürkan Danışan and Cihan Büyüksütçü and Mehmet Balcı and Şinasi Korkmaz and Bilal Akdemir and Adil Akın Yıldıran and Cemal Yaşar. “EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE.” Journal of Istanbul Faculty of Medicine, vol. 84, no. 2, 2021, pp. 149-157. [Database Container], https://doi.org/10.26650/IUITFD.2021.812574

Vancouver

Benli A, Resuloğlu E, Karadağlı İ, Ceylan AN, Yeler MT, Danışan G, Büyüksütçü C, Balcı M, Korkmaz Ş, Akdemir B, Yıldıran AA, Yaşar C. EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE. Journal of Istanbul Faculty of Medicine [Internet]. 17 May. 2024 [cited 17 May. 2024];84(2):149-157. Available from: https://doi.org/10.26650/IUITFD.2021.812574 doi: 10.26650/IUITFD.2021.812574

ISNAD

Benli, Aysun - Resuloğlu, Emir - Karadağlı, İlke - Ceylan, AyşeNur - Yeler, MustafaTaner - Danışan, Gürkan - Büyüksütçü, Cihan - Balcı, Mehmet - Korkmaz, Şinasi - Akdemir, Bilal - Yıldıran, AdilAkın - Yaşar, Cemal. “EVALUATION OF THE CHARACTERISTICS AND CLINICAL RESULTS OF THE PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA IN THE PROVINCE OF MUS: A STATE HOSPITAL EXPERIENCE”. Journal of Istanbul Faculty of Medicine 84/2 (May. 2024): 149-157. https://doi.org/10.26650/IUITFD.2021.812574

Volume 84, Issue 22021, P. 149-157

TIMELINE

Submitted	20.10.2020
Accepted	28.12.2020
Published Online	09.03.2021

LICENCE

Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.

Journal of Istanbul Faculty of Medicine